Skip to main content

King’s People

Dr Katie Doores

Academics
Supervisors

Senior Lecturer

School Academic Lead, Postgraduate Research.

Contact details

Biography

Katie received her PhD in Organic Chemistry from the University of Oxford in 2008 studying carbohydrate chemistry. She then moved to The Scripps Research Institute California for her postdoctoral studies to work with Dennis Burton where she studied HIV glycobiology and HIV broadly neutralising antibodies. In June 2013, Katie was awarded an MRC Career Development Award and moved to King’s College London to start her research lab.

In 2017 Katie was selected as a member of the EMBO Young Investigator Programme. Katie’s research lab is interested in the roles of carbohydrates in host-pathogen interactions with application to the development of carbohydrate-based vaccines and therapeutics, and neutralising antibody responses against pathogenic viruses.

Latest publications

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
Mahil, S. K., Bechman, K., Raharja, A., Domingo-Vila, C., Baudry, D., Brown, M. A., Cope, A. P., Dasandi, T., Graham, C., Khan, H., Lechmere, T., Malim, M. H., Meynell, F., Pollock, E., Sychowska, K., Barker, J. N., Norton, S., Galloway, J. B., Doores, K. J., Tree, T. & 1 others, Smith, C. H., Jan 2022, In: The Lancet Rheumatology. 4, 1, p. e42-e52 Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1016/S2665-9913(21)00333-7
Erratum: Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients (Cancer Cell (2021) 39(11) (1448–1449), (S1535610821005444), (10.1016/j.ccell.2021.10.002))
Harrington, P., Doores, K. J., Saha, C., Saunders, J., Child, F., Dillon, R., Saglam, S., Raj, K., McLornan, D., Avenoso, D., Kordasti, S., O'Reilly, A., Espehana, A., Lechmere, T., Khan, H., Malim, M. H., Harrison, C., Mehra, V. & de Lavallade, H., 13 Dec 2021, In: CANCER CELL. 39, 12, p. 1654 1 p. Research output: Contribution to journal › Comment/debate › peer-review. DOIs: https://doi.org/10.1016/j.ccell.2021.11.011
SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care
Gutmann, C., Takov, K., Burnap, S. A., Singh, B., Ali, H., Theofilatos, K., Reed, E., Hasman, M., Nabeebaccus, A., Fish, M., McPhail, M. J., O'Gallagher, K., Schmidt, L. E., Cassel, C., Rienks, M., Yin, X., Auzinger, G., Napoli, S., Mujib, S. F., Trovato, F. & 17 others, Sanderson, B., Merrick, B., Niazi, U., Saqi, M., Dimitrakopoulou, K., Fernández-Leiro, R., Braun, S., Kronstein-Wiedemann, R., Doores, K. J., Edgeworth, J. D., Shah, A. M., Bornstein, S. R., Tonn, T., Hayday, A. C., Giacca, M., Shankar-Hari, M. & Mayr, M., Dec 2021, In: Nature Communications. 12, 1, 3406. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41467-021-23494-1
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
Harrington, P., de Lavallade, H., Doores, K. J., O'Reilly, A., Seow, J., Graham, C., Lechmere, T., Radia, D., Dillon, R., Shanmugharaj, Y., Espehana, A., Woodley, C., Saunders, J., Curto-Garcia, N., O'Sullivan, J., Raj, K., Kordasti, S., Malim, M. H., Harrison, C. N. & McLornan, D. P., Dec 2021, In: Leukemia. 35, 12, p. 3573-3577 5 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41375-021-01300-7
The legacy of maternal SARS-CoV-2 infection on the immunology of the neonate
Gee, S., Chandiramani, M., Seow, J., Pollock, E., Modestini, C., Das, A., Tree, T., Doores, K., Tribe, R. & Gibbons, D., Dec 2021, In: Nature Immunology. 22, 12, p. 1490-1502 13 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1038/s41590-021-01049-2
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
Khan, H., Winstone, H., Jimenez Guardeno, J., Graham, C., Doores, K., Goujon, C., Matthews, D., Davidson, A., Rihn, S., Palmarini, M., Neil, S. & Malim, M., 9 Nov 2021, (Accepted/In press) In: Plos pathogens. Research output: Contribution to journal › Article › peer-review
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
McKenzie, D. R., Muñoz-Ruiz, M., Monin, L., Alaguthurai, T., Lechmere, T., Abdul-Jawad, S., Graham, C., Pollock, E., Graham, R., Sychowska, K., Seow, J., Tremain, C., Gousis, C., Domingo-Vila, C., Cooper, J., Vidler, J., Owczarczyk, K., Swampillai, A., Kristeleit, H., Malim, M. H. & 8 others, Fields, P., Patten, P. E. M., Papa, S., North, B. V., Tree, T., Doores, K. J., Hayday, A. C. & Irshad, S., 8 Nov 2021, In: CANCER CELL. 39, 11, p. 1445-1447 3 p. Research output: Contribution to journal › Letter › peer-review. DOIs: https://doi.org/10.1016/j.ccell.2021.10.003
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
Harrington, P., Doores, K. J., Saha, C., Saunders, J., Child, F., Dillon, R., Saglam, S., Raj, K., McLornan, D., Avenoso, D., Kordasti, S., O'Reilly, A., Espehana, A., Lechmere, T., Khan, H., Malim, M. H., Harrison, C., Mehra, V. & de Lavallade, H., 8 Nov 2021, In: CANCER CELL. 39, 11, p. 1448-1449 2 p. Research output: Contribution to journal › Letter › peer-review. DOIs: https://doi.org/10.1016/j.ccell.2021.10.002
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort
Granger, L. A., Huettner, I., Debeljak, F., Kaleebu, P., Schechter, M., Tambussi, G., Weber, J., Miro, J. M., Phillips, R., Babiker, A., Cooper, D. A., Fisher, M., Ramjee, G., Fidler, S., Frater, J., Fox, J. & Doores, K. J., 1 Nov 2021, In: AIDS (London, England). 35, 13, p. 2073-2084 12 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1097/QAD.0000000000002988
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia
Harrington, P., Doores, K. J., Radia, D., O'Reilly, A., Lam, H. P. J., Seow, J., Graham, C., Lechmere, T., McLornan, D., Dillon, R., Shanmugharaj, Y., Espehana, A., Woodley, C., Saunders, J., Curto-Garcia, N., O'Sullivan, J., Raj, K., Kordasti, S., Malim, M. H., Harrison, C. & 1 others, de Lavallade, H., Sep 2021, In: British Journal of Haematology. 194, 6, p. 999-1006 8 p. Research output: Contribution to journal › Article › peer-review. DOIs: https://doi.org/10.1111/bjh.17568

View all publications

Katie Doores

24 November 2021

Dr Katie Doores wins prize for outstanding COVID-19 research

Dr Katie Doores has been named as one of the winners of the Medical Research Foundation’s 2021…